PHARMACEUTICAL COMPOSITIONS COMPRISING S1P MODULATOR

PROBLEM TO BE SOLVED: To provide a pharmaceutical composition comprising a sphingosine-1 phosphate (S1P) receptor modulator, in particular a sphingosine-1 phosphate receptor agonist.SOLUTION: The present invention provides a solid pharmaceutical composition suitable for oral administration, comprisi...

Full description

Saved in:
Bibliographic Details
Main Authors COLLEEN RUEGGER, VALAZZA STEPHEN, AMBUEHL MICHAEL, BEYER JUTTA, CARRENO-GOMEZ BEGONA
Format Patent
LanguageEnglish
Japanese
Published 16.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PROBLEM TO BE SOLVED: To provide a pharmaceutical composition comprising a sphingosine-1 phosphate (S1P) receptor modulator, in particular a sphingosine-1 phosphate receptor agonist.SOLUTION: The present invention provides a solid pharmaceutical composition suitable for oral administration, comprising a sphingosine-1 phosphate receptor modulator, and a microcrystalline cellulose, in the absence of a sugar alcohol. The composition is used for treating a subject in need of immunosuppression.SELECTED DRAWING: None 【課題】スフィンゴシン−1ホスフェート(S1P)受容体調節剤、とりわけスフィンゴシン−1ホスフェート受容体アゴニストを含む医薬組成物の提供。【解決手段】経口投与に適した固体医薬組成物であって、スフィンゴシン−1ホスフェート受容体調節剤および微結晶セルロースを含み、糖アルコールを含まない組成物。免疫抑制を必要とする対象を処置するための該組成物。【選択図】なし
Bibliography:Application Number: JP20160185067